IMMUNIC, INC. - Common Stock, par value $0.0001 (IMUX)

CUSIP: 4525EP200

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
+187,584
SEC-reported price per share
$9.30
Number of holders
9
Value change
+$1,228,648
Number of buys
5
Number of sells
2
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
13,647,397

Security key

4525EP200

Report period

Q3 2026

Institutions

9

Top holders

9

Ownership snapshot

Top reported holders of IMUX - IMMUNIC, INC. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Vivo Opportunity Fund Hol...
Disclosed value leader
Commodore Capital LP
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G 3/4/5 13F Lead comparable stake: 10% 13D/G row: Vivo Opportunity Fund Holdings, L.P. Showing 1-6 of 15 holder rows.

Quick read

Vivo Opportunity Fund Holdings, L.P. leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Vivo Opportunity Fund Holdings, L.P.'s linked filing trail.
Comparable ownership Top 5
Vivo Opportunity Fund Holdings, L.P. 10%
Adage Capital Management, L.P. 10%
Janus Henderson Group Ltd. 10%
BIOTECHNOLOGY VALUE FUND L P 10%
Commodore Capital LP 9.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Vivo Opportunity Fund Holdings, L.P.
13D/G
10%
Reported 13D/G · 17 Feb 2026
$17,767,413
29,126,906 shares
$0 17 Feb 2026
Adage Capital Management, L.P.
13D/G
10%
Reported 13D/G · 30 Jun 2025
$8,697,850
10,479,337 shares
+$7,537,012 30 Jun 2025
Janus Henderson Group Ltd.
13D/G
JANUS HENDERSON GROUP PLC
10%
Reported 13D/G · 28 Nov 2025
$8,531,675
12,016,444 shares
+$6,622,427 28 Nov 2025
BIOTECHNOLOGY VALUE FUND L P
13D/G 3/4/5
BVF PARTNERS L P/IL · Director, Other*
10%
Reported 13D/G · 12 Feb 2026
$8,314,667
13,630,601 shares
+$2,345,708 12 Feb 2026
Commodore Capital LP
13D/G
9.9%
Reported 13D/G · 30 Jun 2026
$22,133,059
1,511,821 shares
$0 30 Jun 2026
Avidity Partners Management LP
13D/G 13F
Company
9.9%
Reported 13D/G · 17 Feb 2026
$15,493,835
13,958,410 shares
+$10,277,489 17 Feb 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
9
Shares
1,946,721
Rows available
9
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q1 2026 Across Filers

Q1 2026 holders
3
Q3 2026 holders
9
Holder diff
6
Investor Q1 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q1 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .